Why the study?
Should all patients with atrial fibrillation receive warfarin for stroke prevention?
Population
Patients with atrial fibrillation
Design
Review
Authors
Loading...
May support broader anticoagulant use in AF with lower INR targets; leaves open confirmation by randomized trials.
Should all patients with atrial fibrillation receive warfarin for stroke prevention?
This review highlights the need for wider use of anticoagulants in atrial fibrillation while emphasizing the importance of identifying minimum effective doses to balance stroke prevention and bleeding risks.
Cleland et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: